Back to User profile » Dr Masahiro Seike

Papers published by Dr Masahiro Seike:


Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report

Iso H, Miyanaga A, Kadoma N, Shinbu K, Tozuka T, Murata A, Nishima S, Sato Y, Nakamichi S, Matsumoto M, Noro R, Terasaki Y, Kubota K, Seike M

OncoTargets and Therapy 2023, 16:465-470

Published Date: 23 June 2023

Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report

Misawa K, Nakamichi S, Iida H, Nagano A, Mikami E, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Kubota K, Yamaguchi H, Seike M

OncoTargets and Therapy 2023, 16:65-69

Published Date: 24 January 2023

Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report

Hayashi A, Nakamichi S, Nakayama Y, Nagano A, Mikami E, Takano N, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Terasaki Y, Kubota K, Seike M, Gemma A

OncoTargets and Therapy 2022, 15:637-642

Published Date: 7 June 2022

Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report

Kato Y, Kato Y, Minegishi Y, Suzuki T, Nakamichi S, Matsumoto M, Miyanaga A, Noro R, Kubota K, Terasaki Y, Seike M, Gemma A

OncoTargets and Therapy 2021, 14:5315-5319

Published Date: 23 November 2021

A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab

Sugano T, Seike M, Noro R, Kaburaki S, Tozuka T, Takahashi A, Takano N, Tanaka T, Kashiwada T, Takeuchi S, Minegishi Y, Saito Y, Kubota K, Terasaki Y, Gemma A

OncoTargets and Therapy 2018, 11:5879-5883

Published Date: 17 September 2018

Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression

Tozuka T, Seike M, Minegishi Y, Kitagawa S, Kato T, Takano N, Hisakane K, Takahashi S, Kobayashi K, Kashiwada T, Sugano T, Takeuchi S, Kunugi S, Noro R, Saito Y, Kubota K, Gemma A

OncoTargets and Therapy 2018, 11:5601-5605

Published Date: 7 September 2018